ADAR1 Capital Management reports acquisition of $5.28 in InMed Pharmaceuticals common shares
INM•ADAR1 Capital Management purchased four InMed Pharmaceuticals common shares at $1.32 each, bringing its indirect beneficial ownership to 956,584 shares.
1. Share purchase
ADAR1 Capital Management reported purchasing four InMed Pharmaceuticals common shares at $1.32 each. Indirect beneficial ownership totaled 956,584 shares after the purchase. ADAR1 Capital Management and its manager, Daniel Schneeberger, were identified as 10% owners.
